CAPTRUST Financial Advisors
ASLN

CAPTRUST Financial Advisors’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History

CAPTRUST Financial Advisors’s Portfolio ASLN Stock Details ASLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-25
Closed – – 4289
2022
Q2 		$0 Hold
25
– – ﹤0.01% 5197
2022
Q1 		$1K Buy
+25
New +$929 ﹤0.01% 4777

Other funds holding ASLN

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CAPTRUST Financial Advisors's ASLN Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) in Q3 2022, closing a stake of 25 shares.

CAPTRUST Financial Advisors first reported a position in ASLN in Q1 2022 and held it in 2 quarters. The position peaked at $1K in Q1 2022. 27 funds tracked by Wall St. Rank hold ASLN as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining ASLAN Pharmaceuticals Limited American Depositary Shares position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 25 ASLAN Pharmaceuticals Limited American Depositary Shares shares in Q3 2022.
  • CAPTRUST Financial Advisors first reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares in Q1 2022 and held it in 2 quarters.
  • CAPTRUST Financial Advisors's ASLAN Pharmaceuticals Limited American Depositary Shares position peaked at $1K in Q1 2022.
  • 27 funds tracked by Wall St. Rank held ASLAN Pharmaceuticals Limited American Depositary Shares as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.